
Keywords: گیرنده مانوز 6-فسفات; ER; endoplasmic reticulum; ERT; enzyme replacement therapy; FDA; U.S. Food and Drug Administration; LD; lysosomal disease; M6P; mannose-6-phosphate; M6PR; mannose-6-phosphate receptor; MPS; mucopolysaccharidosis; NPC; Type C Niemann-Pick disease; NPD; Typ